In Brief: Astra's Naropin
Executive Summary
Astra's Naropin: Long-acting injectable amide local anesthetic is "approvable" as of June 28. Naropin (ropivacaine) was recommended for approval by FDA's Anesthetic & Life Support Drugs Advisory Committee in December for obstetric procedures and post-operative pain management ("The Pink Sheet" Dec. 18, 1995, p. 7). Ropivacaine was shown to be less toxic than bupivacaine (Astra's Sensorcaine and Sanofi Winthrop's Marcaine)...